Breaking News Instant updates and real-time market news.

IQV

Iqvia

$240.83 /

-1.44 (-0.59%)

16:17
06/24/21
06/24
16:17
06/24/21
16:17

Iqvia launches Clinical Data Analytics Suite

Iqvia "introduced Clinical Data Analytics Suite, a new SaaS-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single, standardized setting for easier access and use. This produces a scalable repository, that helps meet regulatory requirements, for stakeholders to investigate operational and clinical data. It also drives faster predictive analytics using AI/ML, enabling smarter decisions across all parts of a clinical trial."

IQV Iqvia
$240.83 /

-1.44 (-0.59%)

05/14/21 KeyBanc
Iqvia price target raised to $260 from $255 at KeyBanc
05/12/21 Argus
Iqvia price target raised to $260 from $220 at Argus
04/26/21 Truist
Iqvia price target raised to $260 from $235 at Truist
04/26/21 Barclays
Iqvia price target raised to $260 from $235 at Barclays

TODAY'S FREE FLY STORIES

Recommendations
Rapid7 price target raised to $125 from $110 at Mizuho » 06:51
08/05/21
08/05
06:51
08/05/21
06:51
RPD

Rapid7

$116.34 /

+0.92 (+0.80%)

Mizuho analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPD Rapid7
$116.34 /

+0.92 (+0.80%)

RPD Rapid7
$116.34 /

+0.92 (+0.80%)

08/02/21
Fly Intel: Top five analyst initiations
08/02/21 KeyBanc
Rapid7 initiated with an Overweight at KeyBanc
07/20/21 RBC Capital
Rapid7 price target raised to $120 from $110 at RBC Capital
07/20/21 Truist
Rapid7 price target raised to $110 from $95 at Truist
RPD Rapid7
$116.34 /

+0.92 (+0.80%)

RPD Rapid7
$116.34 /

+0.92 (+0.80%)

Downgrade
Medallia downgraded to Neutral on Thoma Bravo buyout at Baird » 06:51
08/05/21
08/05
06:51
08/05/21
06:51
MDLA

Medallia

$33.71 /

+0.07 (+0.21%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDLA Medallia
$33.71 /

+0.07 (+0.21%)

MDLA Medallia
$33.71 /

+0.07 (+0.21%)

05:12 Today Baird
Medallia downgraded to Neutral from Outperform at Baird
07/27/21 Stifel
Medallia downgraded to Hold from Buy at Stifel
07/27/21 Citi
Medallia downgraded to Neutral from Buy at Citi
07/26/21 Needham
Medallia downgraded to Hold from Buy at Needham
MDLA Medallia
$33.71 /

+0.07 (+0.21%)

MDLA Medallia
$33.71 /

+0.07 (+0.21%)

MDLA Medallia
$33.71 /

+0.07 (+0.21%)

Upgrade
O-I Glass upgraded to Buy after selloff at Seaport Global » 06:50
08/05/21
08/05
06:50
08/05/21
06:50
OI

O-I Glass

/

+

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OI O-I Glass
/

+

OI O-I Glass
/

+

06:20 Today Seaport Global
O-I Glass upgraded to Buy from Neutral at Seaport Global
05/20/21 Longbow
O-I Glass initiated with a Neutral at Longbow
05/03/21 Barclays
O-I Glass upgraded to Equal Weight from Underweight at Barclays
04/26/21 Baird
O-I Glass potential plan of reorganization for Paddock a positive, says Baird
OI O-I Glass
/

+

Recommendations
Western Digital price target raised to $92 from $90 at Mizuho » 06:50
08/05/21
08/05
06:50
08/05/21
06:50
WDC

Western Digital

$64.95 /

-1.12 (-1.70%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDC Western Digital
$64.95 /

-1.12 (-1.70%)

WDC Western Digital
$64.95 /

-1.12 (-1.70%)

08/04/21 Summit Insights
Western Digital downgraded to Hold from Buy at Summit Insights
07/16/21 Wedbush
Seagate price target raised to $85 from $70 at Wedbush
07/01/21 Benchmark
Micron 'record' NAND sales bode well for Western Digital, says Benchmark
06/17/21 Loop Capital
Western Digital, Seagate may benefit from Chia cryptocurrency, says Loop Capital
WDC Western Digital
$64.95 /

-1.12 (-1.70%)

WDC Western Digital
$64.95 /

-1.12 (-1.70%)

WDC Western Digital
$64.95 /

-1.12 (-1.70%)

WDC Western Digital
$64.95 /

-1.12 (-1.70%)

Hot Stocks
Nintendo sold 4.45M Nintendo Switch units in Q1 » 06:50
08/05/21
08/05
06:50
08/05/21
06:50
NTDOY

Nintendo

$63.81 /

-1.03 (-1.59%)

Unit sales for the entire…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

08/02/21 Wedbush
Nintendo selloff may be overdone if OLED, Pokemon deliver, says Wedbush
07/07/21 Jefferies
Jefferies downgrades Nintendo to Hold with only 7% upside seen
07/06/21 Jefferies
Nintendo downgraded to Hold from Buy at Jefferies
05/21/21 Citi
Nintendo downgraded to Neutral from Buy at Citi
NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

Recommendations
Gaming and Leisure Properties price target raised to $52 from $50 at Mizuho » 06:50
08/05/21
08/05
06:50
08/05/21
06:50
GLPI

Gaming and Leisure Properties

$47.99 /

+1.995 (+4.34%)

, VICI

VICI Properties

$30.18 /

-0.07 (-0.23%)

, MGP

MGM Growth

$39.58 /

+2.51 (+6.77%)

Mizuho analyst Haendel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLPI Gaming and Leisure Properties
$47.99 /

+1.995 (+4.34%)

VICI VICI Properties
$30.18 /

-0.07 (-0.23%)

MGP MGM Growth
$39.58 /

+2.51 (+6.77%)

GLPI Gaming and Leisure Properties
$47.99 /

+1.995 (+4.34%)

08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 UBS
Gaming and Leisure Properties upgraded to Buy from Neutral at UBS
06/14/21 Wolfe Research
Gaming and Leisure Properties initiated with a Peer Perform at Wolfe Research
05/24/21 Mizuho
Gaming and Leisure Properties price target raised to $50 from $49 at Mizuho
VICI VICI Properties
$30.18 /

-0.07 (-0.23%)

06/14/21 Wolfe Research
VICI Properties initiated with an Outperform at Wolfe Research
05/05/21 Evercore ISI
VICI Properties downgraded to In Line from Outperform at Evercore ISI
05/04/21 Evercore ISI
VICI Properties downgraded to In Line from Outperform at Evercore ISI
05/03/21
Fly Intel: Top five analyst downgrades
MGP MGM Growth
$39.58 /

+2.51 (+6.77%)

06/14/21 Wolfe Research
MGM Growth initiated with a Peer Perform at Wolfe Research
05/04/21 Morgan Stanley
MGM Growth price target raised to $38 from $34 at Morgan Stanley
05/04/21 BofA
MGM Growth double-downgraded to Underperform from Buy at BofA
05/03/21 Deutsche Bank
MGM Growth price target raised to $40 from $38 at Deutsche Bank
GLPI Gaming and Leisure Properties
$47.99 /

+1.995 (+4.34%)

VICI VICI Properties
$30.18 /

-0.07 (-0.23%)

MGP MGM Growth
$39.58 /

+2.51 (+6.77%)

  • 11
    Mar
  • 04
    Mar
  • 30
    Oct
MGP MGM Growth
$39.58 /

+2.51 (+6.77%)

VICI VICI Properties
$30.18 /

-0.07 (-0.23%)

MGP MGM Growth
$39.58 /

+2.51 (+6.77%)

Hot Stocks
Regeneron sees FY21 capital expenditures $590M-$640M  06:50
08/05/21
08/05
06:50
08/05/21
06:50
REGN

Regeneron

$580.18 /

-6.51 (-1.11%)

 
ShowHide Related Items >><<
REGN Regeneron
$580.18 /

-6.51 (-1.11%)

REGN Regeneron
$580.18 /

-6.51 (-1.11%)

08/02/21 H.C. Wainwright
Regeneron price target raised to $741 from $729 at H.C. Wainwright
07/29/21 H.C. Wainwright
Regeneron price target raised to $729 from $703 at H.C. Wainwright
07/23/21 RBC Capital
Regeneron price target raised to $679 from $629 at RBC Capital
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
REGN Regeneron
$580.18 /

-6.51 (-1.11%)

REGN Regeneron
$580.18 /

-6.51 (-1.11%)

REGN Regeneron
$580.18 /

-6.51 (-1.11%)

REGN Regeneron
$580.18 /

-6.51 (-1.11%)

Earnings
Regeneron reports Q2 EPS $25.80, consensus $17.69 » 06:49
08/05/21
08/05
06:49
08/05/21
06:49
REGN

Regeneron

$580.18 /

-6.51 (-1.11%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$580.18 /

-6.51 (-1.11%)

REGN Regeneron
$580.18 /

-6.51 (-1.11%)

08/02/21 H.C. Wainwright
Regeneron price target raised to $741 from $729 at H.C. Wainwright
07/29/21 H.C. Wainwright
Regeneron price target raised to $729 from $703 at H.C. Wainwright
07/23/21 RBC Capital
Regeneron price target raised to $679 from $629 at RBC Capital
07/09/21 Jefferies
Aslan Pharmaceuticals initiated with a Buy at Jefferies
REGN Regeneron
$580.18 /

-6.51 (-1.11%)

REGN Regeneron
$580.18 /

-6.51 (-1.11%)

REGN Regeneron
$580.18 /

-6.51 (-1.11%)

REGN Regeneron
$580.18 /

-6.51 (-1.11%)

Downgrade
Nevro downgraded to Hold from Buy at Canaccord » 06:49
08/05/21
08/05
06:49
08/05/21
06:49
NVRO

Nevro

$147.83 /

-3.47 (-2.29%)

Canaccord analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

06:10 Today JMP Securities
Nevro price target lowered to $160 from $190 at JMP Securities
06:06 Today Piper Sandler
Nevro downgraded to Neutral from Overweight at Piper Sandler
06:00 Today Citi
Nevro downgraded to Neutral from Buy at Citi
05:57 Today Citi
Nevro downgraded to Neutral from Buy at Citi
NVRO Nevro
$147.83 /

-3.47 (-2.29%)

NVRO Nevro
$147.83 /

-3.47 (-2.29%)

Hot Stocks
Merck reports KEYNOTE-716 trial met primary endpoint » 06:48
08/05/21
08/05
06:48
08/05/21
06:48
MRK

Merck

$75.48 /

-0.93 (-1.22%)

Merck announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$75.48 /

-0.93 (-1.22%)

MRK Merck
$75.48 /

-0.93 (-1.22%)

07/26/21 Truist
Merck assumed with a Buy at Truist
07/26/21 Truist
Merck assumed with a Buy at Truist
07/02/21 Mizuho
Merck gastric cancer withdrawal not meaningful, says Mizuho
07/01/21 Piper Sandler
NGM continued partnership with Merck good news, says Piper Sandler
MRK Merck
$75.48 /

-0.93 (-1.22%)

MRK Merck
$75.48 /

-0.93 (-1.22%)

MRK Merck
$75.48 /

-0.93 (-1.22%)

MRK Merck
$75.48 /

-0.93 (-1.22%)

Earnings
AdaptHealth raises FY21 revenue view to $2.38B-$2.48B from $2.22B-$2.39B » 06:48
08/05/21
08/05
06:48
08/05/21
06:48
AHCO

AdaptHealth

$21.70 /

+0.24 (+1.12%)

FY21 consensus $2.3B.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AHCO AdaptHealth
$21.70 /

+0.24 (+1.12%)

AHCO AdaptHealth
$21.70 /

+0.24 (+1.12%)

07/14/21 Baird
AdaptHealth upgraded to Outperform on increasing investor confidence at Baird
07/14/21 Baird
AdaptHealth upgraded to Outperform from Neutral at Baird
07/08/21 Jefferies
Medicare home oxygen proposal positive for AdaptHealth, says Jefferies
05/07/21 Canaccord
AdaptHealth price target lowered to $44 from $50 at Canaccord
AHCO AdaptHealth
$21.70 /

+0.24 (+1.12%)

  • 06
    Jan
  • 15
    Dec
  • 03
    Sep
AHCO AdaptHealth
$21.70 /

+0.24 (+1.12%)

Upgrade
Editas Medicine upgraded to Outperform from Underperform at Evercore ISI » 06:47
08/05/21
08/05
06:47
08/05/21
06:47
EDIT

Editas Medicine

/

+

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
/

+

EDIT Editas Medicine
/

+

06/03/21 Baird
Editas Medicine assumed with an Outperform at Baird
05/05/21 Chardan
Editas may be positioned for some second half rebound, says Chardan
05/03/21 RBC Capital
Editas Medicine initiated with a Sector Perform at RBC Capital
04/16/21
Fly Intel: Top five analyst initiations
EDIT Editas Medicine
/

+

  • 21
    Jan
EDIT Editas Medicine
/

+

EDIT Editas Medicine
/

+

Recommendations
DTE Energy price target raised to $126 from $123 at Mizuho » 06:47
08/05/21
08/05
06:47
08/05/21
06:47
DTE

DTE Energy

$117.91 /

-0.22 (-0.19%)

Mizuho analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DTE DTE Energy
$117.91 /

-0.22 (-0.19%)

DTE DTE Energy
$117.91 /

-0.22 (-0.19%)

07/28/21 Wells Fargo
DTE Energy price target raised to $128 from $120 at Wells Fargo
07/14/21 Barclays
DTE Energy reinstated with an Equal Weight at Barclays
07/13/21 Goldman Sachs
DTE Energy upgraded to Conviction Buy from Buy at Goldman Sachs
07/09/21 Mizuho
DTE Energy price target lowered to $123 from $146 at Mizuho
DTE DTE Energy
$117.91 /

-0.22 (-0.19%)

Earnings
Thomson Reuters raises FY21 revenue view to up 4%-4.5% from 3.5%-4% » 06:47
08/05/21
08/05
06:47
08/05/21
06:47
TRI

Thomson Reuters

$105.79 /

+0.49 (+0.47%)

Consensus $2.63. Sees…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

07/30/21 RBC Capital
Thomson Reuters price target raised to $112 from $104 at RBC Capital
07/15/21 TD Securities
Thomson Reuters price target raised to C$135 from C$130 at TD Securities
06/03/21 Goldman Sachs
Vertex downgraded to Sell from Neutral at Goldman Sachs
05/05/21 Scotiabank
Thomson Reuters price target raised to C$128 from C$122 at Scotiabank
TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

Earnings
Nintendo reports Q1 EPS Y778.59 vs. Y893.88 last year » 06:47
08/05/21
08/05
06:47
08/05/21
06:47
NTDOY

Nintendo

$63.81 /

-1.03 (-1.59%)

Reports Q1 net sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

08/02/21 Wedbush
Nintendo selloff may be overdone if OLED, Pokemon deliver, says Wedbush
07/07/21 Jefferies
Jefferies downgrades Nintendo to Hold with only 7% upside seen
07/06/21 Jefferies
Nintendo downgraded to Hold from Buy at Jefferies
05/21/21 Citi
Nintendo downgraded to Neutral from Buy at Citi
NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

NTDOY Nintendo
$63.81 /

-1.03 (-1.59%)

Recommendations
General Motors named short-term investment idea at Deutsche Bank » 06:46
08/05/21
08/05
06:46
08/05/21
06:46
GM

General Motors

$52.71 /

-5.21 (-9.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$52.71 /

-5.21 (-9.00%)

GM General Motors
$52.71 /

-5.21 (-9.00%)

08/04/21 Citi
GM reaction 'appears excessive' after 'noisier' than expected Q2, says Citi
08/04/21 Wells Fargo
Wells Fargo expects GM to trade down modestly despite headline beat and raise
08/04/21 Credit Suisse
General Motors' lower 2H outlook 'a reset on expectations,' says Credit Suisse
07/16/21 BofA
General Motors price target raised to $90 from $80 at BofA
GM General Motors
$52.71 /

-5.21 (-9.00%)

GM General Motors
$52.71 /

-5.21 (-9.00%)

GM General Motors
$52.71 /

-5.21 (-9.00%)

GM General Motors
$52.71 /

-5.21 (-9.00%)

Earnings
Thomson Reuters sees Q3 revenue growth 3.5%-4%, consensus $2.87B » 06:46
08/05/21
08/05
06:46
08/05/21
06:46
TRI

Thomson Reuters

$105.79 /

+0.49 (+0.47%)

Sees Q3 organic revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

07/30/21 RBC Capital
Thomson Reuters price target raised to $112 from $104 at RBC Capital
07/15/21 TD Securities
Thomson Reuters price target raised to C$135 from C$130 at TD Securities
06/03/21 Goldman Sachs
Vertex downgraded to Sell from Neutral at Goldman Sachs
05/05/21 Scotiabank
Thomson Reuters price target raised to C$128 from C$122 at Scotiabank
TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

Downgrade
Maxar Technologies downgraded to Hold from Buy at Canaccord » 06:46
08/05/21
08/05
06:46
08/05/21
06:46
MAXR

Maxar Technologies

$34.03 /

-1.32 (-3.73%)

Canaccord analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

07/15/21 Morgan Stanley
Maxar Technologies initiated with an Overweight at Morgan Stanley
07/14/21 Baird
Baird starts Maxar Technologies at Neutral, cautious ahead of Legion launch
07/14/21 Baird
Maxar Technologies initiated with a Neutral at Baird
06/22/21 BofA
BofA starts Maxar Technologies at Neutral, sees runway along with risks
MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

  • 18
    Mar
MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

MAXR Maxar Technologies
$34.03 /

-1.32 (-3.73%)

General news
FX Update: The dollar etched out an eight-day high » 06:45
08/05/21
08/05
06:45
08/05/21
06:45
$ECON

Economic Data

/

+

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
European stock markets have essentially moved sideways » 06:45
08/05/21
08/05
06:45
08/05/21
06:45
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Amarin reports Q2 EPS 2c, consensus (3c) » 06:44
08/05/21
08/05
06:44
08/05/21
06:44
AMRN

Amarin

$4.44 /

+0.15 (+3.50%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRN Amarin
$4.44 /

+0.15 (+3.50%)

AMRN Amarin
$4.44 /

+0.15 (+3.50%)

06/21/21 Northland
Amarin selloff on court decision 'extreme overreaction,' says Northland
05/24/21 JPMorgan
Amarin pullback suggests 'some' share upside, says JPMorgan
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 Goldman Sachs
Amarin downgraded to Sell from Neutral at Goldman Sachs
AMRN Amarin
$4.44 /

+0.15 (+3.50%)

AMRN Amarin
$4.44 /

+0.15 (+3.50%)

AMRN Amarin
$4.44 /

+0.15 (+3.50%)

AMRN Amarin
$4.44 /

+0.15 (+3.50%)

Initiation
Qorvo assumed with a Buy at Benchmark » 06:44
08/05/21
08/05
06:44
08/05/21
06:44
QRVO

Qorvo

$193.84 /

-1.39 (-0.71%)

Benchmark analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QRVO Qorvo
$193.84 /

-1.39 (-0.71%)

QRVO Qorvo
$193.84 /

-1.39 (-0.71%)

05:27 Today Oppenheimer
Qorvo price target raised to $250 from $220 at Oppenheimer
07/28/21 KeyBanc
Apple results moderately positive for iPhone suppliers, says KeyBanc
07/15/21 WestPark Capital
Qorvo initiated with a Buy at WestPark Capital
07/01/21
Fly Intel: Top five analyst initiations
QRVO Qorvo
$193.84 /

-1.39 (-0.71%)

QRVO Qorvo
$193.84 /

-1.39 (-0.71%)

QRVO Qorvo
$193.84 /

-1.39 (-0.71%)

Earnings
AdaptHealth reports Q2 EPS 12c, consensus 22c » 06:44
08/05/21
08/05
06:44
08/05/21
06:44
AHCO

AdaptHealth

$21.70 /

+0.24 (+1.12%)

Reports Q2 revenue $617M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AHCO AdaptHealth
$21.70 /

+0.24 (+1.12%)

AHCO AdaptHealth
$21.70 /

+0.24 (+1.12%)

07/14/21 Baird
AdaptHealth upgraded to Outperform on increasing investor confidence at Baird
07/14/21 Baird
AdaptHealth upgraded to Outperform from Neutral at Baird
07/08/21 Jefferies
Medicare home oxygen proposal positive for AdaptHealth, says Jefferies
05/07/21 Canaccord
AdaptHealth price target lowered to $44 from $50 at Canaccord
AHCO AdaptHealth
$21.70 /

+0.24 (+1.12%)

  • 06
    Jan
  • 15
    Dec
  • 03
    Sep
AHCO AdaptHealth
$21.70 /

+0.24 (+1.12%)

Earnings
Thomson Reuters reports Q2 adjusted EPS 48c, consensus 65c » 06:44
08/05/21
08/05
06:44
08/05/21
06:44
TRI

Thomson Reuters

$105.79 /

+0.49 (+0.47%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

07/30/21 RBC Capital
Thomson Reuters price target raised to $112 from $104 at RBC Capital
07/15/21 TD Securities
Thomson Reuters price target raised to C$135 from C$130 at TD Securities
06/03/21 Goldman Sachs
Vertex downgraded to Sell from Neutral at Goldman Sachs
05/05/21 Scotiabank
Thomson Reuters price target raised to C$128 from C$122 at Scotiabank
TRI Thomson Reuters
$105.79 /

+0.49 (+0.47%)

Recommendations
Lyft price target raised to $88 from $80 at Citi » 06:43
08/05/21
08/05
06:43
08/05/21
06:43
LYFT

Lyft

$49.53 /

-5.855 (-10.57%)

Citi analyst Itay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LYFT Lyft
$49.53 /

-5.855 (-10.57%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

08/04/21 BTIG
Lyft price target lowered to $75 from $80 at BTIG
08/04/21 Truist
Lyft price target raised to $80 from $76 at Truist
08/04/21 Cowen
Lyft price target raised to $80 from $76 at Cowen
08/04/21 Credit Suisse
Lyft price target raised to $84 from $79 at Credit Suisse
LYFT Lyft
$49.53 /

-5.855 (-10.57%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

LYFT Lyft
$49.53 /

-5.855 (-10.57%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.